2018
Bea JW, Funk J, Hetherington-Rauth M, Wertheim BC, Mosquiera L, Thuraisingam R, Lee V, Blew R, Lohman T, Roe DJ, et al. 2018. Anthropometry Versus Imaging for Prediction of Inflammation Among Hispanic Girls. Obesity (Silver Spring). 26:1594–1602. doi:10.1002/oby.22265.
Stokes J, Hoffman EA, Molina MS, Eremija J, Larmonier N, Zeng Y, Katsanis E. 2018 Oct. Bendamustine with Total Body Irradiation Limits Murine Graft-versus-Host Disease in Part Through Effects on Myeloid-Derived Suppressor Cells. Biol Blood Marrow Transplant. doi:10.1016/j.bbmt.2018.10.009.
Scott AJ, Arcaroli JJ, Bagby SM, Yahn R, Huber KM, Serkova NJ, Nguyen A, Kim J, Thorburn A, Vogel J, et al. 2018. Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms. Mol Cancer Ther. 17:2112–2122. doi:10.1158/1535-7163.MCT-17-0131.
Stanton AL, Wiley JF, Krull JL, Crespi CM, Weihs KL. 2018. Cancer-related coping processes as predictors of depressive symptoms, trajectories, and episodes. J Consult Clin Psychol. 86:820–830. doi:10.1037/ccp0000328.
Gharaibeh M, McBride A, Alberts DS, Slack M, Erstad B, Alsaid N, Bootman JL, Abraham I. 2018. Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer. Pharmacoeconomics. 36:1273–1284. doi:10.1007/s40273-018-0678-6.
McGregor H, Sun Z, McCoy D, Kumar V, Conrad M, Wilson M, Cooke D. 2018. Endovascular Biopsy and Endothelial Cell Gene Expression Analysis of Dialysis Arteriovenous Fistulas: A Feasibility Study. J Vasc Interv Radiol. 29:1403–1409.e2. doi:10.1016/j.jvir.2018.04.034.
Tajeu GS, Halanych J, Juarez L, Stone J, Stepanikova I, Green A, Cherrington AL. 2018. Exploring the Association of Healthcare Worker Race and Occupation with Implicit and Explicit Racial Bias. J Natl Med Assoc. 110:464–472. doi:10.1016/j.jnma.2017.12.001.
Rak MA, Buehler J, Zeltzer S, Reitsma J, Molina B, Terhune S, Goodrum F. 2018. Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency. J Virol. 92. doi:10.1128/JVI.00919-18.
Bachman AS, Cohen EL, Collins T, Hatcher J, Crosby R, Vanderpool RC. 2018. Identifying Communication Barriers to Colorectal Cancer Screening Adherence among Appalachian Kentuckians. Health Commun. 33:1284–1292. doi:10.1080/10410236.2017.1351274.
Mantyh PW. 2018 Oct. Mechanisms that drive bone pain across the lifespan. Br J Clin Pharmacol. doi:10.1111/bcp.13801.
Bauman JE, Duvvuri U, Thomas S, Gooding WE, Clump DA, Karlovits B, Wehbe A, Miller FR, Kim S, Sen M, et al. 2018. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives. Cancer. 124:3881–3889. doi:10.1002/cncr.31651.
Adegboyega A, Aroh A, Voigts K, Jennifer H. 2018 Oct. Regular Mammography Screening Among African American (AA) Women: Qualitative Application of the PEN-3 Framework. J Transcult Nurs.:1043659618803146. doi:10.1177/1043659618803146.
Chatterjee S, Chakraborty P, Daenthanasanmak A, Iamsawat S, Andrejeva G, Luevano LA, Wolf M, Baliga U, Krieg C, Beeson CC, et al. 2018 Oct. Targeting PIM Kinase with PD1 inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res. doi:10.1158/1078-0432.CCR-18-0706.
Cartwright TH, Parisi M, Espirito JL, Wilson TW, Pelletier C, Patel M, Babiker HM. 2018. Clinical Outcomes with First-Line Chemotherapy in a Large Retrospective Study of Patients with Metastatic Pancreatic Cancer Treated in a US Community Oncology Setting. Drugs Real World Outcomes. 5:149–159. doi:10.1007/s40801-018-0137-x.
Bigley AB, Baker FL, Simpson RJ. 2018. Cytomegalovirus: an unlikely ally in the fight against blood cancers?. Clin Exp Immunol. 193:265–274. doi:10.1111/cei.13152.
Eshghi N, Garland LL, Nia E, Betancourt R, Krupinski E, Kuo PH. 2018. F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer. J Nucl Med Technol. 46:260–264. doi:10.2967/jnmt.117.204933.
Kerins MJ, Milligan J, Wohlschlegel JA, Ooi A. 2018. Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction. Cancer Sci. 109:2757–2766. doi:10.1111/cas.13701.
Kuo PH, Stuehm C, Squire S, Johnson K. 2018. Meningeal Lymphatic Vessel Flow Runs Countercurrent to Venous Flow in the Superior Sagittal Sinus of the Human Brain. Tomography. 4:99–104. doi:10.18383/j.tom.2018.00013.
Robbins ML, Karan A, López AM, Weihs KL. 2018. Naturalistically observing noncancer conversations among couples coping with breast cancer. Psychooncology. 27:2206–2213. doi:10.1002/pon.4797.
Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW. 2018. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. Pain. 159:1814–1823. doi:10.1097/j.pain.0000000000001278.
Menghrajani K, Boonstra PS, Mercer JA, Perkins C, Gowin KL, Weber AA, Mesa R, Gotlib JR, Wang L, Singer JW, et al. 2018 Sep. Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis. Leuk Lymphoma.:1–7. doi:10.1080/10428194.2018.1509315.
Smalls BL, Aroh A, McQuerry K, Adegboyega A, Schoenberg N, Hatcher J. 2018. Social support and breast cancer screening in rural Appalachia. Psychooncology. 27:2281–2288. doi:10.1002/pon.4828.
Peters TL, Tillotson J, Yeomans AM, Wilmore S, Lemm E, Jiménez-Romero C, Amador LA, Li L, Amin AD, Pongtornpipat P, et al. 2018. Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with Antitumor Activity. Clin Cancer Res. 24:4256–4270. doi:10.1158/1078-0432.CCR-17-3645.
Persky DO, Li H, Rimsza LM, Barr PM, Popplewell LL, Bane CL, Von Gehr A, LeBlanc M, Fisher RI, Smith SM, et al. 2018. A phase I/II trial of vorinostat (SAHA) in combination with rituximab-CHOP in patients with newly diagnosed advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0806. Am J Hematol. 93:486–493. doi:10.1002/ajh.25010.
Malm SW, Amouzougan EA, Klimecki WT. 2018. Fetal bovine serum induces sustained, but reversible, epithelial-mesenchymal transition in the BEAS-2B cell line. Toxicol In Vitro. 50:383–390. doi:10.1016/j.tiv.2018.04.008.
Pagination
- First page
- …
- 18
- 19
- 20
- …
- Last page